Blue Sky Private Equity Hospital Pharmacy Services Fund

Blue Sky Private Equity Hospital Pharmacy Services Fund is a private equity fund operated by Blue Sky Alternative Investments Limited and has approximately $28.9 million in assets. The current minimum investment for Blue Sky Private Equity Hospital Pharmacy Services Fund is $50000. Management owns 16 percent of the fund.

Blue Sky Private Equity Hospital Pharmacy Services Fund Overview

Blue Sky Private Equity Hospital Pharmacy Services Fund Details

Subadviser: No Is Blue Sky Private Equity Hospital Pharmacy Services Fund a subadviser

Other Investment Advisers: No other investment advisors

Solicited: No  Does Blue Sky Private Equity Hospital Pharmacy Services Fund solicit investments?

Rely on Reg D Exemption: Yes  Does Blue Sky Private Equity Hospital Pharmacy Services Fund have a Reg D exemption?

Audited: No  Does Blue Sky Private Equity Hospital Pharmacy Services Fund shave audited financial statements?

Master Fund: No  Is Blue Sky Private Equity Hospital Pharmacy Services Fund a master fund?

Feeder Fund: No  Is Blue Sky Private Equity Hospital Pharmacy Services Fund a feeder fund?

GAAP: No  Does Blue Sky Private Equity Hospital Pharmacy Services Fund use GAAP?

Beneficial Owners: 221  221 has 221 beneficial owners.

Management Ownership: 16% 

Fund of Fund Ownership: 0%  

Non-US Ownership: 99%  Non-US ownership in Blue Sky Private Equity Hospital Pharmacy Services Fund

Auditor(s):

Broker-Dealer(s):

Custodian(s):

Administrator(s):

Blue Sky Private Equity Hospital Pharmacy Services Fund Charts and Graphs

Total AUM: $28.9 million

column_171} total assets are $28.9 million

Rank: 17070 out of 30967 registered private funds

Minimum Investment: $50000

Blue Sky Private Equity Hospital Pharmacy Services Fund has a minimum investment of $50000.

Rank: 21737 out of 30967 registered private funds

Management Ownership: 16%

Blue Sky Private Equity Hospital Pharmacy Services Fund is 16% owned by its management.

Rank: 6822 out of 30967 registered private funds